AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 117 filers reported holding AUDENTES THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $149,000 | +109.9% | 2,508 | 0.0% | 0.00% | – |
| Q3 2019 | $71,000 | -60.3% | 2,508 | -46.9% | 0.00% | – |
| Q2 2019 | $179,000 | -2.7% | 4,726 | 0.0% | 0.00% | – |
| Q1 2019 | $184,000 | +89.7% | 4,726 | 0.0% | 0.00% | – |
| Q4 2018 | $97,000 | +1.0% | 4,726 | +96.0% | 0.00% | – |
| Q3 2018 | $96,000 | +4.3% | 2,411 | 0.0% | 0.00% | – |
| Q2 2018 | $92,000 | +26.0% | 2,411 | 0.0% | 0.00% | – |
| Q1 2018 | $73,000 | -2.7% | 2,411 | 0.0% | 0.00% | – |
| Q4 2017 | $75,000 | – | 2,411 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 1,204,615 | $36,198,681,000 | 11.58% |
| Sofinnova Investments, Inc. | 1,380,303 | $41,478,000 | 7.13% |
| Casdin Capital, LLC | 450,000 | $13,523,000 | 2.38% |
| Foresite Capital Management III, LLC | 315,331 | $9,476,000 | 2.06% |
| Opaleye Management Inc. | 190,000 | $5,709,000 | 1.63% |
| Redmile Group, LLC | 1,308,526 | $39,321,000 | 1.52% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,384,470 | $41,603,000 | 1.44% |
| Orbimed Advisors | 3,522,100 | $105,839,000 | 1.31% |
| Rock Springs Capital Management LP | 565,000 | $16,978,000 | 0.72% |
| Cormorant Asset Management, LP | 322,945 | $9,704,000 | 0.72% |